Safeguarding cancer care in the post COVID-19 world From an interesting editorial in the Lancet Oncology Journal May 2020. During this COVID-19 pandemic it would appear that cancer care has been de-prioritised, delayed and even discontinued. This decision will...
Diabetes and COVID-19 A helpful article published in the Lancet Diabetes and Endocrinology Journal on April 23 by a 19-member panel led by Stefan R. Bornstein from Dresden University. Diabetes is known to be a major risk factor for the development of severe pneumonia...
Our Coronavirus Return to Work Service helps companies and organisations plan for their workforce under the “New Normal”. The service includes testing as well as practical measures. We’ve listed below some thoughts but our approach is to work...
From an interesting review in the BMJ: COVID-19, what do we know so far about a vaccine. The World Health Organisation announced that there are 83 potential COVID-19 vaccines being assessed. 7 are now approved for human testing through clinical trials. So, what...
Covid-19 Immunity The World Health Organisation has said that there is no evidence that people who have recovered from a coronavirus have immunity to the disease. They have, however, said that the antibody tests will be able to measure the level of...
How can we get our population back to work? What do our policy makers in Government need to know about the COVID-19 immunity? A third of the world is still under lockdown as public health measures have been used to reduce the spread of COVID-19 caused by the...
